Positive Breast Cancer

Approx. Rs 36,088 / BottleGet Latest Price

• What it is: Tucatinib is a targeted therapy drug, specifically a tyrosine kinase inhibitor, that works by blocking the HER2 protein. 
• How it works: HER2 is a protein on the surface of some cancer cells that stimulates their growth. Tucatinib binds to the HER2 protein inside the cell, preventing it from sending signals that promote cancer cell growth. 
• What it treats: Tucatinib is used to treat HER2-positive breast cancer that is locally advanced or metastatic (has spread to other parts of the body). 
• How it's used: It is typically used in combination with other medications, such as trastuzumab and capecitabine, as part of a treatment regimen for HER2-positive breast cancer. 
• Brand name: Tucatinib is marketed under the brand name Tukysa. 
• Dosage: The 150mg strength refers to the amount of tucatinib in each tablet. 
• Administration: Tucatinib tablets are taken orally, with or without food, and should be swallowed whole. 
• Other uses: It is also being studied for the treatment of other types of cancer. 

Additional Information: